93° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

8.515 +0.135 (+1.61%)

Streaming Delayed Price Updated: 3:01 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

July 30, 2025

Conference Call Scheduled for August 6, 2025, at 4:30 p.m. ET

From ADMA Biologics, Inc.

Via GlobeNewswire

Is ADMA Biologics Gaining or Losing Market Support? ↗

July 02, 2025

Via Benzinga

ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria ↗

June 13, 2025

ADMA Biologics (NASDAQ:ADMA) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential ↗

June 09, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong growth fundamentals and a technical breakout setup, making it a stock to watch in the biotech sector.

Via Chartmill

How Is The Market Feeling About ADMA Biologics? ↗

June 04, 2025

Via Benzinga

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

ADMA Biologics Earnings Preview ↗

May 06, 2025

Via Benzinga

What's Driving the Market Sentiment Around ADMA Biologics? ↗

March 11, 2025

Via Benzinga

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup ↗

June 07, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout...

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Promising Affordable Growth Stock ↗

June 03, 2025

ADMA Biologics (NASDAQ:ADMA) shows strong growth, reasonable valuation, and solid financial health, making it an attractive candidate for investors seeking affordable growth stocks in the biotech...

Via Chartmill

ADMA BIOLOGICS INC (NASDAQ:ADMA) is not too expensive for the growth it is showing. ↗

May 09, 2025

Discover ADMA BIOLOGICS INC, an undervalued growth gem. NASDAQ:ADMA is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...

Via Chartmill

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings ↗

May 08, 2025

Via Benzinga

Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits ↗

May 08, 2025

The company makes immunoglobulin products using donated plasma.

Via Investor's Business Daily

Topics Earnings

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

May 07, 2025

From ADMA Biologics, Inc.

Via GlobeNewswire

3 Mid-Cap Medical Stocks Outperforming the Market

May 06, 2025

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

Via MarketBeat

Topics Economy

Should you consider ADMA BIOLOGICS INC (NASDAQ:ADMA) for growth investing? ↗

May 05, 2025

A fundamental analysis of (NASDAQ:ADMA): Exploring growth characteristics of ADMA BIOLOGICS INC (NASDAQ:ADMA).

Via Chartmill

Would Mark Minervini consider ADMA BIOLOGICS INC (NASDAQ:ADMA) a top stock pick? ↗

May 01, 2025

A fundamental and technical analysis of (NASDAQ:ADMA): Exploring ADMA BIOLOGICS INC (NASDAQ:ADMA)'s high growth characteristics.

Via Chartmill

ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate ↗

May 01, 2025

ADMA Biologics Inc (NASDAQ:ADMA): A Strong Minervini Trend Template Candidate

Via Chartmill

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

April 30, 2025

Conference Call Scheduled for May 7, 2025, at 4:30 p.m. ET

From ADMA Biologics, Inc.

Via GlobeNewswire

What's Going On With ADMA Stock Monday? ↗

April 28, 2025

ADM shares are trading higher Monday after the company announced the FDA's approval of its yield enhancement process.

Via Benzinga

Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday ↗

April 28, 2025

Via Benzinga

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval ↗

April 28, 2025

The company says a new process will improve its output by 20%, benefitting revenue and earnings later this year.

Via Investor's Business Daily

Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth

April 29, 2025

From FN Media Group LLC

Via GlobeNewswire

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

April 28, 2025

From ADMA Biologics, Inc.

Via GlobeNewswire

Why ADMA BIOLOGICS INC (NASDAQ:ADMA) qualifies as a high growth stock. ↗

April 23, 2025

A fundamental and technical analysis of (NASDAQ:ADMA): Is ADMA BIOLOGICS INC (NASDAQ:ADMA) suited for high growth investing?

Via Chartmill

Investors seeking growth at a reasonable cost should explore ADMA BIOLOGICS INC (NASDAQ:ADMA). ↗

April 16, 2025

Via Chartmill

ADMA Biologics Statement on Tariffs

April 07, 2025

Reiterates Strategic Advantage Through Fully U.S.-Based Manufacturing Operations, Commercialization and End-Market Sales, and Vertically Integrated U.S.-Based Supply Chain

From ADMA Biologics, Inc.

Via GlobeNewswire

What's Driving the Market Sentiment Around ADMA Biologics? ↗

April 02, 2025

Via Benzinga

ADMA BIOLOGICS INC (NASDAQ:ADMA) is showing good growth, while it is not too expensive. ↗

March 20, 2025

NASDAQ:ADMA is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

ADMA Biologics Inc - Common Stock (NQ:ADMA)

All News about ADMA Biologics Inc - Common Stock

Sections

Services